Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

S H KELKAR & CO. vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    S H KELKAR & CO. TATVA CHINTAN PHARMA S H KELKAR & CO./
TATVA CHINTAN PHARMA
 
P/E (TTM) x 31.2 77.0 40.6% View Chart
P/BV x 2.7 5.6 47.5% View Chart
Dividend Yield % 1.0 0.2 602.1%  

Financials

 S H KELKAR & CO.   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    S H KELKAR & CO.
Mar-23
TATVA CHINTAN PHARMA
Mar-23
S H KELKAR & CO./
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1672,649 6.3%   
Low Rs821,606 5.1%   
Sales per share (Unadj.) Rs121.8191.1 63.8%  
Earnings per share (Unadj.) Rs4.520.5 22.2%  
Cash flow per share (Unadj.) Rs10.424.8 41.7%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Avg Dividend yield %1.60.1 1,713.0%  
Book value per share (Unadj.) Rs76.9232.2 33.1%  
Shares outstanding (eoy) m138.4222.17 624.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.011.1 9.2%   
Avg P/E ratio x27.3103.7 26.3%  
P/CF ratio (eoy) x12.085.7 14.0%  
Price / Book Value ratio x1.69.2 17.6%  
Dividend payout %44.09.7 451.3%   
Avg Mkt Cap Rs m17,19247,157 36.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,118386 548.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m16,8654,236 398.1%  
Other income Rs m16657 289.7%   
Total revenues Rs m17,0324,294 396.7%   
Gross profit Rs m1,921572 335.8%  
Depreciation Rs m80596 842.0%   
Interest Rs m23986 277.8%   
Profit before tax Rs m1,044448 233.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m414-7 -5,848.9%   
Profit after tax Rs m630455 138.4%  
Gross profit margin %11.413.5 84.4%  
Effective tax rate %39.7-1.6 -2,509.6%   
Net profit margin %3.710.7 34.8%  
BALANCE SHEET DATA
Current assets Rs m12,0653,136 384.8%   
Current liabilities Rs m7,0872,361 300.1%   
Net working cap to sales %29.518.3 161.5%  
Current ratio x1.71.3 128.2%  
Inventory Days Days173 576.9%  
Debtors Days Days973 13.0%  
Net fixed assets Rs m9,9534,304 231.3%   
Share capital Rs m1,384222 624.5%   
"Free" reserves Rs m9,2604,926 188.0%   
Net worth Rs m10,6445,148 206.8%   
Long term debt Rs m3,18942 7,538.8%   
Total assets Rs m22,0187,439 296.0%  
Interest coverage x5.46.2 86.5%   
Debt to equity ratio x0.30 3,646.2%  
Sales to assets ratio x0.80.6 134.5%   
Return on assets %3.97.3 54.2%  
Return on equity %5.98.8 66.9%  
Return on capital %9.310.3 90.1%  
Exports to sales %4.776.2 6.2%   
Imports to sales %10.956.9 19.1%   
Exports (fob) Rs m7953,229 24.6%   
Imports (cif) Rs m1,8352,409 76.2%   
Fx inflow Rs m7953,229 24.6%   
Fx outflow Rs m1,8352,409 76.2%   
Net fx Rs m-1,041820 -126.9%   
CASH FLOW
From Operations Rs m1,967278 707.9%  
From Investments Rs m-1,029-1,011 101.8%  
From Financial Activity Rs m-1,748378 -462.6%  
Net Cashflow Rs m-882-357 247.3%  

Share Holding

Indian Promoters % 48.2 72.0 66.9%  
Foreign collaborators % 10.8 0.0 -  
Indian inst/Mut Fund % 9.1 16.5 55.4%  
FIIs % 8.9 3.7 242.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.1 28.0 146.7%  
Shareholders   46,379 73,730 62.9%  
Pledged promoter(s) holding % 7.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare S H KELKAR & CO. With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    GHCL    


More on S H KELKAR & CO. vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

S H KELKAR & CO. vs TATVA CHINTAN PHARMA Share Price Performance

Period S H KELKAR & CO. TATVA CHINTAN PHARMA
1-Day -1.53% 0.02%
1-Month -0.27% 9.97%
1-Year 80.70% -23.68%
3-Year CAGR 16.38% -18.73%
5-Year CAGR 7.22% -11.70%

* Compound Annual Growth Rate

Here are more details on the S H KELKAR & CO. share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of S H KELKAR & CO. hold a 59.0% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of S H KELKAR & CO. and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, S H KELKAR & CO. paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 44.0%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.

You may visit here to review the dividend history of S H KELKAR & CO., and the dividend history of TATVA CHINTAN PHARMA.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.